Jane Street »

Cyclacel Pharmaceuticals shares owned by Jane Street

Quarter-by-quarter ownership of Cyclacel Pharmaceuticals (BGMS) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Cyclacel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cyclacel Pharmaceuticals held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclacel Pharmaceuticals by Jane Street

Quarter filed Position value Share count Share price at filing
2026-06-30 $15k 16k 0.91

More positions owned by Jane Street

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
NVIDIA Corporation Call Option (NVDA)
Advanced Micro Devices Call Option (AMD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Sandisk Corp Call Option (SNDK)
Spdr Gold Tr Gold Shs Call Option (GLD)
Amazon Call Option (AMZN)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Broadcom Call Option (AVGO)

View all positions for Jane Street

Top funds holding Cyclacel Pharmaceuticals

Citadel Advisors
Jane Street
Tower Research Capital
UBS Group
SBI Securities
Advisor Group Holdings
Archer Investment Corp

View all funds holding Cyclacel Pharmaceuticals